XML 15 R70.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidating Financial Information (Details 2) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Apr. 01, 2012
Cash Flow from Operating Activities:    
Net cash provided by operating activities $ 45,437 $ 66,283
Cash provided by operating activities - discontinued operations 0 2,197
Net cash provided by operating activities 45,437 68,480
Cash Flow from Investing Activities:    
Proceeds from sale of property and equipment 4 158
Proceeds from sale of assets held for sale 1,602 297
Proceeds from sale of assets held for sale   297
Change in restricted cash and investments 2,330 960
Capital expenditures (11,402) (47,916)
Cash (used in) provided by investing activities - continuing operations (7,466) (46,501)
Cash used in investing activities - discontinued operations 0 (1,085)
Net Cash Provided by (Used in) Investing Activities (7,466) (47,586)
Cash Flow from Financing Activities:    
Proceeds from long term debt 410,000 53,000
Income tax benefit of equity compensation 1,127 (342)
Distribution to noncontrolling interests 0 (5,758)
Debt issuance costs (5,650) (44)
Payments on long-term debt (358,438) (64,075)
Proceeds from the exercise of stock options 3,049 231
Cash dividends paid (35,711) 0
Proceeds from reissuance of treasury stock in connection with ESPP 66 0
Payments for retirement of common stock 0 (1,035)
Net cash provided by (used in) financing activities 14,443 (18,023)
Effect of Exchange Rate Changes on Cash and Cash Equivalents (445) 995
Net Increase in Cash and Cash Equivalents 51,969 3,866
Cash and Cash Equivalents, beginning of period 31,755 43,378
Cash and Cash Equivalents, end of period 83,724 47,244
The GEO Group Inc.
   
Cash Flow from Operating Activities:    
Net cash provided by operating activities   24,885
Cash provided by operating activities - discontinued operations   1,738
Net cash provided by operating activities 8,032 26,623
Cash Flow from Investing Activities:    
Proceeds from sale of property and equipment 0 0
Proceeds from sale of assets held for sale 0  
Proceeds from sale of assets held for sale   0
Change in restricted cash and investments (124) 0
Capital expenditures (1,414) (27,046)
Cash (used in) provided by investing activities - continuing operations   (27,046)
Cash used in investing activities - discontinued operations   (260)
Net Cash Provided by (Used in) Investing Activities (1,538) (27,306)
Cash Flow from Financing Activities:    
Proceeds from long term debt 410,000 53,000
Income tax benefit of equity compensation 1,127 (342)
Distribution to noncontrolling interests   0
Debt issuance costs (5,650) (6)
Payments on long-term debt (351,153) (57,278)
Proceeds from the exercise of stock options 3,049 231
Cash dividends paid (35,711)  
Proceeds from reissuance of treasury stock in connection with ESPP 66  
Payments for retirement of common stock   (1,035)
Net cash provided by (used in) financing activities 21,728 (5,430)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net Increase in Cash and Cash Equivalents 28,222 (6,113)
Cash and Cash Equivalents, beginning of period 4,764 15,086
Cash and Cash Equivalents, end of period 32,986 8,973
Combined Subsidiary Guarantors [Member]
   
Cash Flow from Operating Activities:    
Net cash provided by operating activities   19,198
Cash provided by operating activities - discontinued operations   1,205
Net cash provided by operating activities 26,708 20,403
Cash Flow from Investing Activities:    
Proceeds from sale of property and equipment 4 149
Proceeds from sale of assets held for sale 1,602  
Proceeds from sale of assets held for sale   297
Change in restricted cash and investments (1,145) 0
Capital expenditures (9,624) (20,316)
Cash (used in) provided by investing activities - continuing operations   (19,870)
Cash used in investing activities - discontinued operations   (825)
Net Cash Provided by (Used in) Investing Activities (9,163) (20,695)
Cash Flow from Financing Activities:    
Proceeds from long term debt 0 0
Income tax benefit of equity compensation 0 0
Distribution to noncontrolling interests   0
Debt issuance costs 0 0
Payments on long-term debt (377) (340)
Proceeds from the exercise of stock options 0 0
Cash dividends paid 0  
Proceeds from reissuance of treasury stock in connection with ESPP 0  
Payments for retirement of common stock   0
Net cash provided by (used in) financing activities (377) (340)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net Increase in Cash and Cash Equivalents 17,168 (632)
Cash and Cash Equivalents, beginning of period 1,917 3,092
Cash and Cash Equivalents, end of period 19,085 2,460
Combined Non-Guarantor Subsidiaries [Member]
   
Cash Flow from Operating Activities:    
Net cash provided by operating activities   22,200
Cash provided by operating activities - discontinued operations   (746)
Net cash provided by operating activities 10,697 21,454
Cash Flow from Investing Activities:    
Proceeds from sale of property and equipment 0 9
Proceeds from sale of assets held for sale     
Proceeds from sale of assets held for sale     
Change in restricted cash and investments 3,599 960
Capital expenditures (364) (554)
Cash (used in) provided by investing activities - continuing operations   415
Cash used in investing activities - discontinued operations   0
Net Cash Provided by (Used in) Investing Activities 3,235 415
Cash Flow from Financing Activities:    
Proceeds from long term debt 0 0
Income tax benefit of equity compensation 0 0
Distribution to noncontrolling interests   (5,758)
Debt issuance costs 0 (38)
Payments on long-term debt (6,908) (6,457)
Proceeds from the exercise of stock options 0 0
Cash dividends paid 0  
Proceeds from reissuance of treasury stock in connection with ESPP 0  
Payments for retirement of common stock   0
Net cash provided by (used in) financing activities (6,908) (12,253)
Effect of Exchange Rate Changes on Cash and Cash Equivalents (445) 995
Net Increase in Cash and Cash Equivalents 6,579 10,611
Cash and Cash Equivalents, beginning of period 25,074 25,200
Cash and Cash Equivalents, end of period $ 31,653 $ 35,811